INFINANT HEALTH

Serial Number 97584896
606

Registration Progress

Application Filed
Sep 9, 2022
Under Examination
Dec 12, 2023
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered

Trademark Image

INFINANT HEALTH

Basic Information

Serial Number
97584896
Filing Date
September 9, 2022
Published for Opposition
October 17, 2023
Abandonment Date
July 15, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 15, 2024
Classes
042

Rights Holder

INFINANT HEALTH, INC

03
Address
2121 2nd St, STE C108
Davis, CA 95618

Ownership History

Evolve BioSystems Inc.

Original Applicant
03
Davis, CA

INFINANT HEALTH, INC

New Owner Before Publication #1
03
Davis, CA

INFINANT HEALTH, INC

Owner at Publication
03
Davis, CA

Legal Representation

Attorney
John Gary Maynard, III

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description Documents
Jul 15, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 15, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 8, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 8, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 8, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 7, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 27, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 13, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases

Additional Information

Design Mark
The mark consists of six gold circles and the stylized wording "INFINANT HEALTH" in black.
Color Claim
The color(s) black and gold is/are claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTH"